AbCellera Biologics Inc. — Form D
AbCellera Biologics Inc. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2018-08-10. The offering totals $7.7M, of which $7.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-08-10
- Form: D
- Accession: 0001567619-18-000363
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.7M
- Amount sold: $7.7M
- Investors: 1
- Date of first sale: 2018-08-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-318995
Issuer
- Name: AbCellera Biologics Inc.
- CIK: 0001703057
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Incorporated: 2012
- Address: 2215 Yukon Street, VANCOUVER, A1, V5Y 0A1
- Phone: (604) 559-9005
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Andrew Booth | Director | Vancouver, A1 |
| John Hamer | Director | Durham, NC |
| Doug Janzen | Director | Park City, UT |
| Doug Janzen | Executive Officer | Park City, UT |
| Veronique Lecault | Director | Vancouver, A1 |
| Veronique Lecault | Executive Officer | Vancouver, A1 |
| Michael Hayden | Director | Vancouver, A1 |
| Andrew Booth | Executive Officer | Vancouver, A1 |
| Carl Hansen | Director | St. Helier, Y9 |
| Carl Hansen | Executive Officer | St. Helier, Y9 |
| Stimart Tryn | Executive Officer | Vancouver, A1 |
Other filings by this issuer (3)
More